Fig. 2.
Effect of myoinositol on the levels of P-Akt and P-ERK in bronchial lesions analyzed with immunohistochemistry by per-site and subject analyses. Total baseline bronchial sites (103) include 31 dysplastic sites, 67 hyper/metaplastic sites, and 5 normal sites. Top, the staining index was expressed as mean ± SE; bottom, changes in staining indices for P-Akt and P-ERK from all pretreatment and posttreatment bronchial epithelial sites.